Ligand Pharmaceuticals Inc. (LGND) News

Latest headlines that mention LGND, newest first · each headline opens the original publisher

LGND quote

Last price: $295.00
Day change: +0.59%
Next earnings: 2026-11-05

Quote & chart Expected move Insider trading IV rank history

LGND headlines

last 30 days

Seeking Alpha 13d ago

Ligand Pharma a new Outperform at Barclays on biopharma royalty aggregation

General T2BCS LGND

Seeking Alpha 14d ago

Ligand, AvenCell ink financing deal worth up to $47M for CAR-T therapies

General T2LGND

Investing.com 14d ago

Oppenheimer reiterates Ligand Pharma stock rating on AvenCell deal

General T3LGND OPY

Investing.com 16d ago

Sydnexis sells Ryjunea royalty rights to Ligand for $23M

General T3LGND

Seeking Alpha News 19d ago

Ligand Pharmaceuticals: The Multiple Is The Whole Bet; Hold

General T2LGND

Seeking Alpha News 20d ago

Ligand Pharmaceuticals: Owning It Gives You A Stake Across Biotech

General T2LGND

Also mentioned with LGND

30d

BCS1
OPY1

Headlines that tag both tickers

LGND news alerts

Get an alert by email or push when a new headline mentions LGND.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.